Neutrophil‑to‑lymphocyte ratio reflects lung injury in thoracic radiotherapy and immune checkpoint inhibitors combination therapy with different sequences-Reference-Cited by-同舟云学术

Neutrophil‑to‑lymphocyte ratio reflects lung injury in thoracic radiotherapy and immune checkpoint inhibitors combination therapy with different sequences

Published:2024-01-18 Issue:3 Volume:20 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Tong Anna¹,Wang Zewen²,Wang Sinian³,Li Xiaoxue⁴,Jiang Qisheng³,Li Fengsheng³,Yan Peng²

Affiliation:

1. Radiation Oncology Department, 960 Hospital of the PLA Joint Logistics Support Force, Jinan, Shandong 250031, P.R. China

2. Oncology Department, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250013, P.R. China

3. Department of Nuclear Radiation Injury and Monitoring, The PLA Rocket Force Characteristic Medical Center, Beijing 100032, P.R. China

4. Pathology Department, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250013, P.R. China

Publisher

Spandidos Publications

Reference35 articles.

1. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N Engl J Med,2015

2. Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): A randomised, open-label, controlled, phase 3 trial;Shitara;Lancet,2018

3. Metastatic basal cell carcinoma with amplification of PD-L1: Exceptional response to anti-PD1 therapy;Ikeda;NPJ Genom Med,2016

4. Stereotactic radiation therapy augments antigen-specific PD-1-Mediated antitumor immune responses via cross-presentation of tumor antigen;Sharabi;Cancer Immunol Res,2015

5. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice;Deng;J Clin Invest,2014